Edgewell Personal Care Company

The stock trades at a P/S ratio of 0.5x, well below the peer average of 2.3x and a fair ratio of 0.6x, suggesting significant upside. A DCF model estimates intrinsic value at $79.13, implying the market is heavily underpricing Edgewell's future cash flow generation potential.

The most widely followed analyst narrative pegs fair value at $24.50, framing the stock as overvalued relative to its current trading price. UBS maintains a Neutral rating with a $29 target, and the average analyst price target of $26.83 sits nearly 10% below the last close of $29.66.

Edgewell's aggressive investment in brand innovation — including digital-first campaigns for Hawaiian Tropic and Cremo, and new Hydro Silk packaging — is already driving market share gains. These initiatives are expected to support above-category sales growth and improved pricing mix, positively impacting future revenue and gross margins.

Despite brand investment efforts, Edgewell continues to face structural pressure from mature categories like Wet Shave and Sun Care, combined with retailer destocking and higher promotional spending. Stronger retailer bargaining power could weigh on volumes, pricing, and the broader margin rebuild story.

Edgewell's board rejected a $30-per-share unsolicited takeover bid from Yellow Wood Partners as too low, signaling management's conviction that the company's intrinsic value and future prospects exceed current market pricing. The market responded positively, with shares jumping 13.7% on the news.

Rejecting a $30 per share offer — a premium above recent trading levels — raises questions about whether the board is setting unrealistically high expectations. With five-year total shareholder returns still negative and the stock trading below the rejected bid price, investors may question whether management's optimism is warranted.